公开(公告)号：EP4410376A2

公开(公告)日：2024-08-07

申请号：EP24161083.1

申请日：2016-11-02

申请人： Regents of the University of Minnesota

发明人： OLIN, Michael

IPC分类号： A61P35/02

CPC分类号： A61K39/39 ,  C07K7/06 ,  C07K7/08 ,  A61K2039/54520130101 ,  A61K2039/5556120130101 ,  A61K2039/58520130101 ,  C07K14/70503 ,  A61K39/0011 ,  A61P35/02 ,  A61K31/203 ,  A61K31/404 ,  A61K31/675 ,  A61K31/7068 ,  A61K38/2013 ,  A61K2239/4720230501 ,  A61K39/4644 ,  A61K39/4611

摘要： The present invention provides in certain embodiments compositions comprising at least one CD200 inhibitor, and methods of reversing or modulating immune suppression in a patient having a disease or disorder arising from abnormal cell growth, function or behaviour, which method comprises administering to a patient in need thereof a CD200 inhibitor composition.

公开(公告)号：EP3370763A1

公开(公告)日：2018-09-12

申请号：EP16862903.8

申请日：2016-11-02

申请人： Regents of the University of Minnesota

发明人： OLIN, Michael

IPC分类号： A61K39/00 ,  A61K39/39 ,  C07K7/06 ,  C07K7/08

CPC分类号： A61K39/0011 ,  A61K9/0019 ,  A61K31/203 ,  A61K31/404 ,  A61K31/675 ,  A61K31/7068 ,  A61K38/2013 ,  A61K39/39 ,  A61K2039/545 ,  A61K2039/55516 ,  A61K2039/55561 ,  A61K2039/585 ,  A61K2039/6081 ,  A61K2039/80 ,  A61K2300/00 ,  A61P35/02 ,  C07K7/06 ,  C07K7/08

摘要： The present invention provides in certain embodiments compositions comprising at least one CD200 inhibitor, and methods of reversing or modulating immune suppression in a patient having a disease or disorder arising from abnormal cell growth, function or behavior, which method comprises administering to a patient in need thereof a CD200 inhibitor composition.

公开(公告)号：EP4410376A3

公开(公告)日：2024-10-30

申请号：EP24161083.1

申请日：2016-11-02

申请人： Regents of the University of Minnesota

发明人： OLIN, Michael

IPC分类号： A61K39/00 ,  A61K39/39 ,  C07K7/06 ,  C07K7/08 ,  C07K14/705 ,  A61K38/20 ,  A61K9/00 ,  A61K31/203 ,  A61K31/404 ,  A61K31/675 ,  A61K31/7068 ,  A61P35/02

摘要： The present invention provides in certain embodiments compositions comprising at least one CD200 inhibitor, and methods of reversing or modulating immune suppression in a patient having a disease or disorder arising from abnormal cell growth, function or behaviour, which method comprises administering to a patient in need thereof a CD200 inhibitor composition.

公开(公告)号：EP3911357A1

公开(公告)日：2021-11-24

申请号：EP20703675.7

申请日：2020-01-13

申请人： Regents of the University of Minnesota

发明人： OLIN, Michael

IPC分类号： A61K38/17 ,  A61P35/00 ,  A61K39/00 ,  A61K9/00 ,  A61K31/4745 ,  A61K38/10